As of 2025-12-16, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is 4.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.58 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is 16.0%.
The range of the Relative Valuation is 3.34 - 5.96 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 22.0x | 20.4x |
| Forward P/E multiples | 15.5x - 21.7x | 17.2x |
| Fair Price | 3.34 - 5.96 | 4.15 |
| Upside | -6.7% - 66.5% | 16.0% |
| Date | P/E |
| 2025-12-12 | 20.40 |
| 2025-12-11 | 20.97 |
| 2025-12-10 | 21.03 |
| 2025-12-09 | 20.57 |
| 2025-12-08 | 19.77 |
| 2025-12-05 | 19.83 |
| 2025-12-04 | 21.25 |
| 2025-12-03 | 21.25 |
| 2025-12-02 | 19.94 |
| 2025-12-01 | 19.94 |
| 2025-11-28 | 19.94 |
| 2025-11-26 | 22.00 |
| 2025-11-25 | 17.84 |
| 2025-11-24 | 18.92 |
| 2025-11-21 | 18.01 |
| 2025-11-20 | 18.06 |
| 2025-11-19 | 18.12 |
| 2025-11-18 | 17.72 |
| 2025-11-17 | 17.84 |
| 2025-11-14 | 17.89 |
| 2025-11-13 | 19.20 |
| 2025-11-12 | 17.72 |
| 2025-11-11 | 16.47 |
| 2025-11-10 | 14.42 |
| 2025-11-07 | 10.94 |
| 2025-11-06 | 11.68 |
| 2025-11-05 | 11.74 |
| 2025-11-04 | 10.66 |
| 2025-11-03 | 10.60 |
| 2025-10-31 | 10.94 |
| 2025-10-30 | 8.55 |
| 2025-10-29 | 8.60 |
| 2025-10-28 | 8.78 |
| 2025-10-27 | 9.29 |
| 2025-10-24 | 9.46 |
| 2025-10-23 | 9.29 |
| 2025-10-22 | 8.95 |
| 2025-10-21 | 8.89 |
| 2025-10-20 | 8.78 |
| 2025-10-17 | 8.15 |
| 2025-10-16 | 8.83 |
| 2025-10-15 | 9.17 |
| 2025-10-14 | 8.43 |
| 2025-10-13 | 8.43 |
| 2025-10-10 | 9.03 |
| 2025-10-09 | 10.09 |
| 2025-10-08 | 9.00 |
| 2025-10-07 | 8.66 |
| 2025-10-06 | 8.43 |
| 2025-10-03 | 8.83 |